FDA gets power to set infant formula safety limits—but enforcement details unclear
H.R. 9788 — FORMULA Act of 2026 · Filed by Brian Mast (R-FL) · 5 cosponsors · Introduced Jul 20, 2026 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires the FDA to set legal limits on contaminants (heavy metals, microplastics, pesticides, and other harmful substances) in infant formula, and to enforce those limits through testing and record-keeping requirements on manufacturers. Manufacturers must test their products, keep records for at least two years, and the FDA must report annually to Congress on violations and contaminant levels found.
Why we flagged it
The bill's operative mechanism is the establishment and enforcement of contaminant limits in infant formula—a direct regulatory safety measure protecting a vulnerable population. The acronym (FORMULA Act) is a playful framing device but does not obscure the bill's actual function.
What the text implies
- The 180-day implementation timeline may create a compliance cliff for smaller manufacturers with limited testing infrastructure, potentially consolidating market share toward larger producers with existing quality-assurance systems.
- Annual congressional reporting of specific contaminant concentrations and manufacturer violations creates a public accountability mechanism that may drive market pressure on non-compliant brands independent of regulatory enforcement.
- The definition of 'contaminant' is broad and includes emerging substances (microplastics, cyanotoxins) not yet subject to established testing protocols, potentially requiring manufacturers to develop new analytical methods at significant cost.
- The bill does not specify enforcement penalties or recall authority, leaving the mechanism for removing non-compliant formula from shelves to existing FDA authority under the FDCA—a potential gap if the agency lacks resources.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Ordinary parents and infants benefit from enforceable safety standards that reduce exposure to neurotoxic contaminants in a critical food source. The bill imposes compliance costs on manufacturers but does not restrict citizens' access to formula or shift liability away from producers.
Who stands to gain
- infant formula manufacturers with existing quality-control and testing infrastructure
- laboratory testing and analytical services providers
- water treatment and source-water management companies
Named in the bill
FDA, HHS Secretary, infant formula manufacturers, Federal Food, Drug, and Cosmetic Act (FDCA), Section 412 FDCA
Where it stands
5 cosponsors: 5 Republicans.
- Jul 20, 2026 — Introduced · Congress.gov: “Introduced in House”
- Jul 20, 2026 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (3,471 characters) on Aug 12, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“FDA gets power to set infant formula safety limits—but enforcement details unclear” QuorumCivic. https://share.quorumcivic.app/bill/119/hr9788 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.